American Journal of Cardiology
Volume 97, Issue 9 , Pages 1358-1364, 1 May 2006

Mechanism of Cardiac Output Gain from Cardiac Resynchronization Therapy in Patients With Coronary Artery Disease or Idiopathic Dilated Cardiomyopathy

  • Tushar V. Salukhe, MRCP

      Affiliations

    • National Heart and Lung Institute, London, United Kingdom
    • Royal Brompton Hospital, London, United Kingdom
    • Corresponding Author InformationCorresponding author: Tel: 44-20-7352-8121; fax: 44-20-7351-8510.
  • ,
  • Darrel P. Francis, MD

      Affiliations

    • International Centre for Circulatory Health, St. Mary’s Hospital, London, United Kingdom
  • ,
  • Michelle Morgan, BA

      Affiliations

    • Royal Brompton Hospital, London, United Kingdom
  • ,
  • Jonathan R. Clague, MD

      Affiliations

    • Royal Brompton Hospital, London, United Kingdom
  • ,
  • Richard Sutton, DSc (Med)

      Affiliations

    • National Heart and Lung Institute, London, United Kingdom
    • Royal Brompton Hospital, London, United Kingdom
  • ,
  • Philip Poole-Wilson, MD

      Affiliations

    • National Heart and Lung Institute, London, United Kingdom
    • Royal Brompton Hospital, London, United Kingdom
  • ,
  • Michael Y. Henein, PhD

      Affiliations

    • National Heart and Lung Institute, London, United Kingdom
    • Royal Brompton Hospital, London, United Kingdom

Received 7 August 2005; received in revised form 21 November 2005; accepted 21 November 2005. published online 21 March 2006.

The mechanisms underlying cardiac resynchronization therapy have consistently been studied at rest and remain ill defined. Peak stress total isovolumic time (t-IVT) is a major determinant of cardiac output (CO) in chronic heart failure. In this study, pharmacologic stress was used to assess the effects of atrioventricular (AV) delay shortening and ventricular resynchronization elements of cardiac resynchronization therapy. Thirty patients undergoing cardiac resynchronization therapy were studied <6 months after implantation. t-IVT and CO were measured during native activation (left bundle branch block), AV delay shortening (right ventricular dual-chamber pacing), and full resynchronization (atrio-biventricular pacing). Full resynchronization shortened peak stress t-IVT by 9.4 ± 6.2 s/min (p <0.001) and increased peak stress CO by 0.9 ± 0.4 L/min (p <0.001), with the effects in individual patients showing a large correlation (r = −0.64, p <0.001). In contrast, simple AV delay shortening did not shorten peak stress t-IVT nor increase peak stress CO, nor was CO at rest affected by full resynchronization or AV delay shortening. Of all measurements during native activation, the best predictor of gain in peak stress CO from full resynchronization was peak stress t-IVT (r = 0.75, p <0.001), with every 5 s/min increment in peak stress t-IVT during native activation predicting a 6% gain in peak stress CO. No conventional measures during native activation at rest or during stress (including QRS duration, the Tei index, tissue Doppler intraventricular delay, and t-IVT at rest) added significant additional information. In conclusion, only during stress does resynchronization consistently increase CO. Second, little of this increment in CO is achieved by AV delay shortening alone. Third, under native activation, long t-IVT during peak stress is the single best predictor of resynchronization-mediated increment in peak stress CO.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Salukhe was supported by the British Heart Foundation (FS/04/007), London, United Kingdom.

PII: S0002-9149(06)00159-7

doi:10.1016/j.amjcard.2005.11.053

American Journal of Cardiology
Volume 97, Issue 9 , Pages 1358-1364, 1 May 2006